Erlotinib u nemocných s nemalobuněčným karcinomem plic (NSCLC) účinný u všech podskupin nemocných i v České republice
| Title in English | Erlotinib in patients with non-small cell lung cancer (NSCLC): Efficacy in all subgroups of patients even in the Czech Republic |
|---|---|
| Authors | |
| Year of publication | 2010 |
| Type | Article in Proceedings |
| Conference | Edukační sborník |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | Erlotinib; NSCLC; Czech Republic |
| Description | A multi-centre study confirms efficacy of Erlotinib in treatment of NSCLC in all subgroups of patients with non-small cell lung cancer (NSCLC). Efficacy in all patient subgroups was confirmed even in the Czech Republic |
| Related projects: |